Le Lézard
Classified in: Science and technology, Business
Subjects: CCA, FVT

Equifax Announces Earnings Release Date and Conference Call for Fourth Quarter 2023 Results


ATLANTA, Jan. 25, 2024 /PRNewswire/ -- Equifax® (NYSE: EFX) will announce its financial results for the fourth quarter ended December 31, 2023 in a release to be issued on February 7 after the market closes.

Equifax will host a conference call at 8:30 a.m. Eastern Time (ET) on February 8, in which senior management will discuss financial and business results for the quarter. Related presentation materials will be published on investor.equifax.com on February 8 at 6:30 a.m. ET.

Conference Call:
US/Canada: (877) 559-1190
International: (201) 389-0916

Please dial the appropriate number 5-10 minutes prior to the call to complete registration. Name and affiliation/company are required to join the call.

Webcast:
To view the webcast and slide presentation, please click the link and enter your information to be connected. The link becomes active 15 minutes prior to the scheduled start time.

An audio replay of the conference call will be available on investor.equifax.com beginning on February 9.

ABOUT EQUIFAX INC.
At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.com.

FOR MORE INFORMATION:
Sam McKinstry for Equifax
samuel.mckinstry@equifax.com

 

SOURCE Equifax Inc.


These press releases may also interest you

at 09:00
Pomerantz LLP announces that a class action lawsuit has been filed against Sonder Holdings Inc. ("Sonder" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free,...

at 09:00
The Prime Minister, Justin Trudeau, today issued the following statement on the National Day of Mourning: "Today, on the National Day of Mourning, we come together to honour the Canadians who have been injured, killed, or sick because of workplace...

at 09:00
Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 09:00
Pomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") and certain officers.  The class action, filed in the United States District Court for the Southern District of...

at 09:00
Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") and certain officers. The class action, filed in the United States District Court for the Southern District of...

at 09:00
Pomerantz LLP announces that a class action lawsuit has been filed against HireRight Holdings Corporation ("HireRight" or the "Company") and certain officers. The class action, filed in the United States District Court for the Middle District of...



News published on and distributed by: